news
Global cephalosporin drugs market projected to rise 3.34 percent
The worldwide trade of the cephalosporin class of antibiotics will increase to $14.1 billion by the end of 2025.
List view / Grid view
Antibiotics
Filter the results
news
Three pharma companies accused of breaking competition law
The CMA alleges that a pharmaceutical company agreed to buy equal quantities of a pill from two drug suppliers, breaking competition law.
news
NHS to launch subscription service to encourage R&D
The NHS is set to launch a new payment method for antibiotic development to incentivise pharmaceutical companies.
news
Combination therapy ‘favourable’ in long-term acne treatment
According to Rutgers researchers, physicians are scaling back on prescribing antibiotics for long-term acne treatment in favour of a combination of therapies.
news
Big pharma accused of no action on antibiotic threat
The pharmaceutical industry needs to match words with action on researching new antibiotics to address the threat posed by drug-resistant superbugs...
news
Expansion of the global antibiotics market size
The global antibiotics market is set to increase at a CAGR of 4 percent to $62.06 billion, due to the rising prevalence of infectious diseases...
Whitepapers/App Notes/Posters
Whitepaper: Analytical criteria in bacterial endotoxin testing using LAL and rFC
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
news
Biomanufacturing sector set to ‘boost its efficiency’
The next five years will see game-changing improvements made in upstream, downstream and continuous bioprocessing, predicts one industry specialist...
Whitepapers/App Notes/Posters
Whitepaper: BIOshell™ IgG 1000 Å C4 UHPLC column for improved biomacromolecule separations
Monoclonal antibodies (mAbs) are widely manufactured by many biopharmaceutical companies to treat a myriad of diseases ranging from Alzheimer’s disease, Parkinson’s disease, ulcerative colitis, and many types of cancers...
news
New compound as effective as FDA-approved drugs against life-threatening infections
Researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the FDA to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.
news
Oral antibiotics may raise risk of kidney stones
Paediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones...
news
Antibiotic use increases risk of severe viral disease in mice
Killing gut bacteria with drugs weakens immune response...
news
Scientists develop rapid test that determines antibiotic resistance
Scientists in Germany have developed a test using electric fields and Raman spectroscopy to ascertain specific antibiotic resistance of pathogens and thus enable the prescription of effective treatment.
news
Antibiotics may impact cancer treatment efficacy
Improper use of antibiotics may have an unintended consequence of hampering cancer treatments...
article
DNA microarrays and multidrug resistant bacteria
In parallel with the use of a wide range of antibiotics for treating infectious diseases worldwide, antimicrobial resistance has significantly increased. For this reason, the application of an advanced pangenomic technique like DNA microarray can be an effective, rapid, accurate, sensitive, specific and flexible methodology for detecting, identifying and determining…